842
Participants
Start Date
March 28, 2019
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
Conditional ACT subsidy, Arm 1 levels
The subsidy levels for participants randomly assigned to Arm 1 are: No subsidy for RDT (price to consumer=$0.40); 100% ACT subsidy (price to consumer=0).
Conditional ACT subsidy, Arm 2 levels
The subsidy levels for participants randomly assigned to Arm 2 are: No subsidy for RDT (price to consumer=$0.40); 67% ACT subsidy (price to consumer=$0.10-0.40, dependent upon patient age).
Conditional ACT subsidy, Arm 3 levels
The subsidy levels for participants randomly assigned to Arm 3 are: 50% subsidy for RDT (price to consumer=$0.20); 100% ACT subsidy (price to consumer=0).
Conditional ACT subsidy, Arm 4 levels
The subsidy levels for participants randomly assigned to Arm 4 are: 50% subsidy for RDT (price to consumer=$0.20); 67% ACT subsidy (price to consumer=$0.10-0.40, dependent upon patient age)
Moi University, Eldoret
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Moi University
OTHER
Clinton Health Access Initiative, Nigeria
OTHER
Duke University
OTHER